Related Experiment Video
Updated: May 1, 2026

09:02
Fabricating a UV-Vis and Raman Spectroscopy Immunoassay Platform
Published on: November 10, 2016
10.3K
Multiplexed lateral flow immunoassays using high photostability gap-enhanced Raman nanotags: Highly sensitive, rapid,
Xudong Jin1, Yumin Zhang1, Qingsheng Guo1
1School of Biomedical Engineering/Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, PR China.
Biosensors & Bioelectronics
|March 19, 2025
Summary
This study introduces a novel Raman scattering-based test for rapid, sensitive detection of cardiac injury and infectious diseases. The new point-of-care test (POCT) significantly improves sensitivity for biomarkers like cardiac troponin I and viral proteins.
Area of Science:
- Analytical Chemistry
- Biomedical Engineering
- Biotechnology
Background:
- Accurate point-of-care tests (POCTs) are crucial for early diagnosis of diseases.
- Current lateral flow immunoassays (LFIA) often lack sensitivity and quantitative accuracy.
- There is a need for rapid, multiplexed diagnostic tools for infectious diseases and myocardial injury.
Purpose of the Study:
- To develop a sensitive and multiplexed POCT using surface-enhanced Raman scattering (SERS).
- To integrate gap-enhanced Raman tags (GERTs) for enhanced signal and photostability.
- To achieve simultaneous detection of multiple biomarkers for improved diagnostics.
Main Methods:
- Developed a SERS-based LFIA incorporating ultrahigh photostability GERTs.
- Utilized Raman comprehensive full-spectrum analysis and portable Raman detectors.
- Validated the assay for cardiac troponin I (cTnI), SARS-CoV-2 spike protein (RSSP), influenza A (FluA), and influenza B (FluB) detection.
Main Results:
- Achieved a detection limit of 0.65 pg/mL for cTnI, an order of magnitude more sensitive than fluorescent LFIAs.
- Demonstrated 2-3 orders of magnitude sensitivity improvement compared to colloidal gold for viral detection.
- Enabled simultaneous detection of RSSP, FluA, and FluB on a single test line.
- Obtained results within 15 minutes using a portable Raman detector.
Conclusions:
- The developed GERTs-based LFIA offers rapid, ultrasensitive, and quantitative detection capabilities.
- This method addresses the limitations of conventional LFIAs for critical conditions like myocardial infarction.
- The technology facilitates the development of advanced POCTs for clinical and analytical chemistry applications.

